Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sharlaa Badal-Faesen
Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings
AIDS
Infectious Diseases
Allergy
Immunology
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings From the START Bone Mineral Density Substudy, a Randomized Trial
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Related publications
A Qualitative PCR Minipool Strategy to Screen for Virologic Failure and Antiretroviral Drug Resistance in South African Patients on First-Line Antiretroviral Therapy
Journal of Clinical Virology
Virology
Infectious Diseases
HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial
Journal of the International Association of Providers of AIDS Care
Dermatology
Infectious Diseases
Immunology
An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases
Infectious Diseases
Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Random Lopinavir Concentrations Predict Resistance on Lopinavir-Based Antiretroviral Therapy
International Journal of Antimicrobial Agents
Medicine
Infectious Diseases
Microbiology
Pharmacology
Mortality and Long-Term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir
Pediatric Infectious Disease Journal
Child Health
Infectious Diseases
Pediatrics
Perinatology
Microbiology
PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Lack of Effect From a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir
Pharmacotherapy
Pharmacology
HIV Drug Resistance Mutations in Patients With HIV and HIV-TB Coinfection After Failure of First-Line Therapy: A Prevalence Study in a Resource-Limited Setting
Journal of the International Association of Providers of AIDS Care
Dermatology
Infectious Diseases
Immunology
